SunLink Health Systems, Inc.

As of March 31, 2025, SunLink Health Systems, Inc. has 7.04M shares outstanding.

As of March 31, 2025, SunLink Health Systems, Inc. trades at a trailing price-to-earnings ratio of 4.08. The price-to-sales ratio is 0.23, and the price-to-book ratio stands at 2.89.

These figures are as of March 31, 2025. The EV/Sales ratio of 0.01 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of March 31, 2025, SunLink Health Systems, Inc. maintains a current ratio of 3.91, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2025, SunLink Health Systems, Inc. posted a return on equity (ROE) of 109.63, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 10.26, measuring how efficiently the asset base is converted into earnings. Inventory turnover of 12.66 indicates how many times SunLink Health Systems, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2025, SunLink Health Systems, Inc. posted a gross margin of 38.45, reflecting its pricing power and cost economics. The operating margin of -11.46 and net profit margin of 5.55 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2025. Free cash flow yield is negative at -41.60: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

SunLink Health Systems, Inc.'s most recent stock split took place on November 21, 1994 with a 10:11 split ratio.

As of March 31, 2025, SunLink Health Systems, Inc. has an Altman Z-Score of 2.88, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.